Clinical trial

Mechanisms of Resistance to PSMA Radioligand Therapy

NCT05435495

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2021-10-21

PhaseN/A

Study timeline

Study start (actual)2021-10-21Date precision: day

Registry last updated2026-03-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

Single-photon emission computed tomographyPROCEDURE

Blood DrawPROCEDURE

Tumor BiopsyPROCEDURE

Sponsors & collaborators

University of California, San Franciscolead sponsor

National Cancer Institute (NCI)collaborator

Prostate Cancer Foundationcollaborator

Mapped research locations

New YorkNew York, United States1 Los AngelesCalifornia, United States1 San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05435495 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.